Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

Current applications and limitations of surgical treatments for movement disorders

(2017) Paul Krack et al.   MOVEMENT DISORDERS

The emerging science of precision medicine and pharmacogenomics for Parkinson's disease

(2017) Haydeh Payami   MOVEMENT DISORDERS

Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease

(2017) Maria Pia Giannoccaro et al.   MOVEMENT DISORDERS

Mild cognitive impairment as a risk factor for Parkinson's disease dementia

(2017) Jeroen Hoogland et al.   MOVEMENT DISORDERS

Targeting α-Synuclein as a therapy for Parkinson's disease: The battle begins

(2017) C. Warren Olanow et al.   MOVEMENT DISORDERS

Precision medicine for disease modification in Parkinson disease

(2017) Alberto J. Espay et al.   Nature Reviews Neurology

Selective neuronal vulnerability in Parkinson disease

(2017) D. James Surmeier et al.   NATURE REVIEWS NEUROSCIENCE

Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease

(2017) Fabio A. Zucca et al.   PROGRESS IN NEUROBIOLOGY

Genetics of Synucleinopathies

(2017) Robert L. Nussbaum   Cold Spring Harbor Perspectives in Medicine

α-synuclein genetic variability: A biomarker for dementia in Parkinson disease

(2016) Ilaria Guella et al.   ANNALS OF NEUROLOGY

Pathological α-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients

(2016) Morten Gersel Stokholm et al.   ANNALS OF NEUROLOGY

Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N -Methyl-D-Aspartate Receptor Subunit

(2016) Alessandro Tozzi et al.   BIOLOGICAL PSYCHIATRY

Consensus Paper: Towards a Systems-Level View of Cerebellar Function: the Interplay Between Cerebellum, Basal Ganglia, and Cortex

(2016) Daniele Caligiore et al.   CEREBELLUM

Novel Levodopa Formulations for Parkinson’s Disease

(2016) Maria Eliza Freitas et al.   CNS DRUGS

Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia

(2016) Dhanya Vijayakumar et al.   DRUGS

New and emerging medical therapies in Parkinson’s disease

(2016) Mitesh Lotia et al.   EXPERT OPINION ON PHARMACOTHERAPY

Assessment of α-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study

(2016) Dolores Vilas et al.   LANCET NEUROLOGY

Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers

(2016) Dolores Vilas et al.   MOVEMENT DISORDERS

Subthalamic synchronized oscillatory activity correlates with motor impairment in patients with Parkinson's disease

(2016) Wolf-Julian Neumann et al.   MOVEMENT DISORDERS

The emerging role of transcranial magnetic resonance imaging-guided focused ultrasound in functional neurosurgery

(2016) David Weintraub et al.   MOVEMENT DISORDERS

New methods for the assessment of Parkinson's disease (2005 to 2015): A systematic review

(2016) Álvaro Sánchez-Ferro et al.   MOVEMENT DISORDERS

Motor and Nonmotor Features of Carriers of the p.A53T Alpha-Synuclein Mutation: A Longitudinal Study

(2016) Dimitra Papadimitriou et al.   MOVEMENT DISORDERS

Genetics of movement disorders in the next-generation sequencing era

(2016) Simone Olgiati et al.   MOVEMENT DISORDERS

Advances in surgery for movement disorders

(2016) Nathan C. Rowland et al.   MOVEMENT DISORDERS

Motor subtype in Parkinson's disease: Different disorders or different stages of disease?

(2016) John G. Nutt   MOVEMENT DISORDERS

Biomarkers for dementia and mild cognitive impairment in Parkinson's disease

(2016) Manuel Delgado-Alvarado et al.   MOVEMENT DISORDERS

Oscillatory activity in the basal ganglia and deep brain stimulation

(2016) Jorge Guridi et al.   MOVEMENT DISORDERS

Study ofLRRK2variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration

(2016) Monica Sanchez-Contreras et al.   MOVEMENT DISORDERS

Abolishing the 1-year rule: How much evidence will be enough?

(2016) Ronald B. Postuma et al.   MOVEMENT DISORDERS

Arguing against the proposed definition changes of PD

(2016) Bradley F. Boeve et al.   MOVEMENT DISORDERS

Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies

(2016) Maria Xilouri et al.   MOVEMENT DISORDERS

Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links

(2016) Tim Moors et al.   MOVEMENT DISORDERS

Nonmotor features of Parkinson's disease subtypes

(2016) Connie Marras et al.   MOVEMENT DISORDERS

Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force

(2016) Connie Marras et al.   MOVEMENT DISORDERS

A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration

(2016) Dominic M. Walsh et al.   NATURE REVIEWS NEUROSCIENCE

Accuracy of clinical diagnosis of Parkinson disease

(2016) Giovanni Rizzo et al.   NEUROLOGY

Levodopa therapy for Parkinson disease: Table

(2016) Peter A. LeWitt et al.   NEUROLOGY

Understanding Dopaminergic Cell Death Pathways in Parkinson Disease

(2016) Patrick P. Michel et al.   NEURON

A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor

(2016) W. Jeffrey Elias et al.   NEW ENGLAND JOURNAL OF MEDICINE

Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses

(2016) Vanesa Bellou et al.   PARKINSONISM & RELATED DISORDERS

Pedunculopontine Nucleus Region Deep Brain Stimulation in Parkinson Disease: Surgical Techniques, Side Effects, and Postoperative Imaging

(2016) Clement Hamani et al.   STEREOTACTIC AND FUNCTIONAL NEUROSURGERY

α-Synuclein-Based Animal Models of Parkinson's Disease: Challenges and Opportunities in a New Era

(2016) Naomi P. Visanji et al.   TRENDS IN NEUROSCIENCES

Is Alpha-Synuclein Loss-of-Function a Contributor to Parkinsonian Pathology? Evidence from Non-human Primates

(2016) Timothy J. Collier et al.   Frontiers in Neuroscience

Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial

(2015) C. Warren Olanow et al.   ANNALS OF NEUROLOGY

Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study

(2015) Ronald B. Postuma et al.   ANNALS OF NEUROLOGY

Clinical correlates of raphe serotonergic dysfunction in early Parkinson’s disease

(2015) Zahi Qamhawi et al.   BRAIN

The relative phases of basal ganglia activities dynamically shape effective connectivity in Parkinson's disease

(2015) Hayriye Cagnan et al.   BRAIN

Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson’s disease

(2015) Flavia Niccolini et al.   BRAIN

Longitudinal changes in free-water within the substantia nigra of Parkinson’s disease

(2015) Edward Ofori et al.   BRAIN

Baseline and longitudinal grey matter changes in newly diagnosed Parkinson’s disease: ICICLE-PD study

(2015) Elijah Mak et al.   BRAIN

Dopamine Is Required for the Neural Representation and Control of Movement Vigor

(2015) Babita Panigrahi et al.   CELL

Protective glove use and hygiene habits modify the associations of specific pesticides with Parkinson's disease

(2015) Melissa Furlong et al.   ENVIRONMENT INTERNATIONAL

Flies with Parkinson's disease

(2015) Roeland Vanhauwaert et al.   EXPERIMENTAL NEUROLOGY

Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease

(2015) Ravindran Kumaran et al.   HUMAN MOLECULAR GENETICS

MRI signs of multiple system atrophy preceding the clinical diagnosis: the case for an imaging-supported probable MSA diagnostic category

(2015) T A Mestre et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Multitarget disease-modifying therapy in Parkinson's disease?

(2015) Paolo Calabresi et al.   LANCET NEUROLOGY

Vascular Parkinsonism: Deconstructing a Syndrome

(2015) Joaquin A. Vizcarra et al.   MOVEMENT DISORDERS

Neuropathology of α-synuclein propagation and braak hypothesis

(2015) Heather McCann et al.   MOVEMENT DISORDERS

A scan without evidence is not evidence of absence: Scans without evidence of dopaminergic deficit in a symptomatic leucine-rich repeat kinase 2 mutation carrier

(2015) Daryl J. Wile et al.   MOVEMENT DISORDERS

Basic science breaks through: New therapeutic advances in Parkinson's disease

(2015) Patrik Brundin et al.   MOVEMENT DISORDERS

Clinical and scientific perspectives on movement disorders: Stanley Fahn's contributions

(2015) Joseph Jankovic et al.   MOVEMENT DISORDERS

Genetic risk loci for Parkinson's disease: Moving from state to trait?

(2015) Meike Kasten et al.   MOVEMENT DISORDERS

Parkinsonism following neuroleptic exposure: A double-hit hypothesis?

(2015) Roberto Erro et al.   MOVEMENT DISORDERS

Genetic risk and age in Parkinson's disease: Continuum not stratum

(2015) Mike A. Nalls et al.   MOVEMENT DISORDERS

Development of Passive Immunotherapies for Synucleinopathies

(2015) Ann-Louise Bergström et al.   MOVEMENT DISORDERS

Disease-modifying strategies for Parkinson's disease

(2015) Lorraine V. Kalia et al.   MOVEMENT DISORDERS

Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease

(2015) Gabriel Castellanos et al.   MOVEMENT DISORDERS

MDS clinical diagnostic criteria for Parkinson's disease

(2015) Ronald B. Postuma et al.   MOVEMENT DISORDERS

MDS research criteria for prodromal Parkinson's disease

(2015) Daniela Berg et al.   MOVEMENT DISORDERS

Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase

(2015) Javier Pagonabarraga et al.   MOVEMENT DISORDERS

Alpha-synuclein propagation: New insights from animal models

(2015) Benjamin Dehay et al.   MOVEMENT DISORDERS

Depression and subsequent risk of Parkinson disease: A nationwide cohort study

(2015) H. Gustafsson et al.   NEUROLOGY

Parkinson disease and incidental Lewy body disease

(2015) Diego Iacono et al.   NEUROLOGY

Clinical implications of delayed orthostatic hypotension

(2015) Christopher H. Gibbons et al.   NEUROLOGY

Did α-Synuclein and Glucocerebrosidase Coevolve? Implications for Parkinson’s Disease

(2015) James M. Gruschus   PLoS One

New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression

(2015) Seyed-Mohammad Fereshtehnejad et al.   JAMA Neurology

The disease intersection of susceptibility and exposure: Chemical exposures and neurodegenerative disease risk

(2014) Caroline M. Tanner et al.   Alzheimers & Dementia

Do prions cause Parkinson disease?: The evidence accumulates

(2014) C. Warren Olanow   ANNALS OF NEUROLOGY

Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson’s disease with hallucinations

(2014) Jennifer G. Goldman et al.   BRAIN

Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson’s disease

(2014) Hélène Hall et al.   BRAIN

Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells

(2014) Alisdair McNeill et al.   BRAIN

Substantia Nigra and Parkinson's Disease: A Brief History of Their Long and Intimate Relationship

(2014) Martin Parent et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Imaging the Aetiology of Sleep Disorders in Dementia and Parkinson’s Disease

(2014) Nicola Pavese   Current Neurology and Neuroscience Reports

Rebuilding the nigrostriatal dopamine pathway: 30 years and counting

(2014) Timothy J. Collier   EXPERIMENTAL NEUROLOGY

Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients

(2014) Marios Politis et al.   JOURNAL OF CLINICAL INVESTIGATION

Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models

(2014) D. Games et al.   JOURNAL OF NEUROSCIENCE

Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives

(2014) Anthony H V Schapira et al.   LANCET

The medical treatment of Parkinson disease from James Parkinson to George Cotzias

(2014) Stanley Fahn   MOVEMENT DISORDERS

Patients with scans without evidence of dopaminergic deficit: A long-term follow-up study

(2014) Amit Batla et al.   MOVEMENT DISORDERS

The Onset of Nonmotor Symptoms in Parkinson's disease (The ONSET PDStudy)

(2014) Claustre Pont-Sunyer et al.   MOVEMENT DISORDERS

Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts

(2014) Julia Kraemmer et al.   MOVEMENT DISORDERS

Clinical spectrum of levodopa-induced complications

(2014) Camila Catherine Aquino et al.   MOVEMENT DISORDERS

Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease

(2014) Daniela Berg et al.   MOVEMENT DISORDERS

Levodopa: Effect on cell death and the natural history of Parkinson's disease

(2014) C. Warren Olanow   MOVEMENT DISORDERS

The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases

(2014) Gesine Respondek et al.   MOVEMENT DISORDERS

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

(2014) Mike A Nalls et al.   NATURE GENETICS

Imaging prodromal Parkinson disease: The Parkinson Associated Risk Syndrome Study

(2014) D. Jennings et al.   NEUROLOGY

Functional connectivity and cognitive decline over 3 years in Parkinson disease

(2014) K. T. E. Olde Dubbelink et al.   NEUROLOGY

Accuracy of Parkinson disease diagnosis unchanged in 2 decades

(2014) A. H. Rajput et al.   NEUROLOGY

Functional connectivity in the basal ganglia network differentiates PD patients from controls

(2014) K. Szewczyk-Krolikowski et al.   NEUROLOGY

Differentiating drug-induced parkinsonism from Parkinson's disease: An update on non-motor symptoms and investigations

(2014) Francesco Brigo et al.   PARKINSONISM & RELATED DISORDERS

Neurodegenerative Disorder Risk in Idiopathic REM Sleep Behavior Disorder: Study in 174 Patients

(2014) Alex Iranzo et al.   PLoS One

Instrumented Functional Reach Test Differentiates Individuals at High Risk for Parkinson’s Disease from Controls

(2014) Sandra E. Hasmann et al.   Frontiers in Aging Neuroscience

Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson Disease

(2014) Michael A. Schwarzschild et al.   JAMA Neurology

Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys

(2013) Ariadna Recasens et al.   ANNALS OF NEUROLOGY

Environmental Toxins and Parkinson's Disease

(2013) Samuel M. Goldman   Annual Review of Pharmacology and Toxicology

Rhythm-specific modulation of the sensorimotor network in drug-naïve patients with Parkinson’s disease by levodopa

(2013) Fabrizio Esposito et al.   BRAIN

Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gait

(2013) Brett W. Fling et al.   BRAIN

The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson’s disease

(2013) Daniel García-Lorenzo et al.   BRAIN

A practical approach to diagnosing adult onset leukodystrophies

(2013) R. M. Ahmed et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial

(2013) Jeffrey Cummings et al.   LANCET

Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities

(2013) Daniela Berg et al.   LANCET NEUROLOGY

Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial

(2013) Anthony HV Schapira et al.   LANCET NEUROLOGY

MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study

(2013) Nir Lipsman et al.   LANCET NEUROLOGY

Trophic Factor Gene Therapy for Parkinson's Disease

(2013) Jeffrey H. Kordower et al.   MOVEMENT DISORDERS

Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?

(2013) C. Warren Olanow et al.   MOVEMENT DISORDERS

Exposure to pesticides or solvents and risk of Parkinson disease

(2013) G. Pezzoli et al.   NEUROLOGY

The spectrum of nonmotor symptoms in early Parkinson disease

(2013) T. K. Khoo et al.   NEUROLOGY

Criteria for the diagnosis of corticobasal degeneration

(2013) M. J. Armstrong et al.   NEUROLOGY

Probing and Regulating Dysfunctional Circuits Using Deep Brain Stimulation

(2013) Andres M. Lozano et al.   NEURON

The Heterogeneity of Early Parkinson’s Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients

(2013) Roberto Erro et al.   PLoS One

Glucocerebrosidase in the pathogenesis and treatment of Parkinson disease: Fig. 1.

(2013) Anthony H. V. Schapira et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series

(2013) Carlos H. Schenck et al.   SLEEP MEDICINE

Parkinson's Disease and Parkinsonism: Neuropathology

(2013) D. W. Dickson   Cold Spring Harbor Perspectives in Medicine

Parkin Disease

(2013) Karen M. Doherty et al.   JAMA Neurology

Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3T and systematic review with meta-analysis

(2013) Stefan T. Schwarz et al.   NeuroImage-Clinical

Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains

(2012) Matthew E. Gegg et al.   ANNALS OF NEUROLOGY

How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder

(2012) R. B. Postuma et al.   BRAIN

Resting state functional connectivity of the striatum in Parkinson’s disease

(2012) Carl D. Hacker et al.   BRAIN

Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?

(2012) Glenda Halliday et al.   Expert Review of Neurotherapeutics

A role for locus coeruleus in Parkinson tremor

(2012) Ioannis U. Isaias et al.   Frontiers in Human Neuroscience

Calcium, Bioenergetics, and Neuronal Vulnerability in Parkinson's Disease

(2012) D. James Surmeier et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Normal pressure hydrocephalus or progressive supranuclear palsy? A clinicopathological case series

(2012) Nadia K. Magdalinou et al.   JOURNAL OF NEUROLOGY

Extracellular Alpha-Synuclein Oligomers Modulate Synaptic Transmission and Impair LTP Via NMDA-Receptor Activation

(2012) M. J. Diogenes et al.   JOURNAL OF NEUROSCIENCE

Polychlorinated biphenyls in prospectively collected serum and Parkinson's disease risk

(2012) Marc G. Weisskopf et al.   MOVEMENT DISORDERS

Parkinson's disease patients show reduced cortical-subcortical sensorimotor connectivity

(2012) Michael Sharman et al.   MOVEMENT DISORDERS

Defining at-risk populations for Parkinson's disease: Lessons from ongoing studies

(2012) Daniela Berg et al.   MOVEMENT DISORDERS

Is alpha-synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases

(2012) Kathleen M. Shannon et al.   MOVEMENT DISORDERS

Caffeine and risk of Parkinson's disease in a large cohort of men and women

(2012) Natalia Palacios et al.   MOVEMENT DISORDERS

A single-question screen for rapid eye movement sleep behavior disorder: A multicenter validation study

(2012) Ronald B. Postuma et al.   MOVEMENT DISORDERS

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

(2012) Irene Litvan et al.   MOVEMENT DISORDERS

Toward a redefinition of Parkinson's disease

(2012) Matthew B. Stern et al.   MOVEMENT DISORDERS

Advancing neurotrophic factors as treatments for age-related neurodegenerative diseases: developing and demonstrating “clinical proof-of-concept” for AAV-neurturin (CERE-120) in Parkinson's disease

(2012) Raymond T. Bartus et al.   NEUROBIOLOGY OF AGING

Oscillating central motor networks in pathological tremors and voluntary movements. What makes the difference?

(2012) M. Muthuraman et al.   NEUROIMAGE

A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease

(2012) I. H. Richard et al.   NEUROLOGY

Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease

(2012) J. M. Milber et al.   NEUROLOGY

Pathological  -Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice

(2012) K. C. Luk et al.   SCIENCE

Vitamin K2 Is a Mitochondrial Electron Carrier That Rescues Pink1 Deficiency

(2012) M. Vos et al.   SCIENCE

Neuropathology underlying clinical variability in patients with synucleinopathies

(2011) Glenda M. Halliday et al.   ACTA NEUROPATHOLOGICA

A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease

(2011) Alexander Zimprich et al.   AMERICAN JOURNAL OF HUMAN GENETICS

VPS35 Mutations in Parkinson Disease

(2011) Carles Vilariño-Güell et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Cognitive-Behavioral Therapy for Depression in Parkinson's Disease: A Randomized, Controlled Trial

(2011) Roseanne D. Dobkin et al.   AMERICAN JOURNAL OF PSYCHIATRY

Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor

(2011) Rick C. Helmich et al.   ANNALS OF NEUROLOGY

Seven-tesla magnetic resonance images of the substantia nigra in Parkinson disease

(2011) Dae-Hyuk Kwon et al.   ANNALS OF NEUROLOGY

Cerebral Glucose Metabolic Features of Parkinson Disease and Incident Dementia: Longitudinal Study

(2011) N. I. Bohnen et al.   JOURNAL OF NUCLEAR MEDICINE

Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study

(2011) Alex Iranzo et al.   LANCET NEUROLOGY

A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials

(2011) Anthony E. Lang   MOVEMENT DISORDERS

Akinetic-rigid and tremor-dominant Parkinson's disease patients show different patterns of FP-CIT Single photon emission computed tomography

(2011) Carsten Eggers et al.   MOVEMENT DISORDERS

Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts

(2011) Kurt A. Jellinger   MOVEMENT DISORDERS

Parkinson's disease: The quintessential neuropsychiatric disorder

(2011) Daniel Weintraub et al.   MOVEMENT DISORDERS

Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism

(2011) S. Pappata et al.   NEUROLOGY

Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease

(2011) A. F. Ramlackhansingh et al.   NEUROLOGY

Use of ibuprofen and risk of Parkinson disease

(2011) X. Gao et al.   NEUROLOGY

Mitochondria: The Next (Neurode)Generation

(2011) Eric A. Schon et al.   NEURON

Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death

(2011) Laura A. Volpicelli-Daley et al.   NEURON

Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

(2010) Thomas G. Beach et al.   ACTA NEUROPATHOLOGICA

Why have we failed to achieve neuroprotection in Parkinson's disease?

(2010) C. Warren Olanow et al.   ANNALS OF NEUROLOGY

Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder

(2010) Ronald B. Postuma et al.   ANNALS OF NEUROLOGY

Age-specific progression of nigrostriatal dysfunction in Parkinson's disease

(2010) Raúl de la Fuente-Fernández et al.   ANNALS OF NEUROLOGY

Dopamine Agonist Withdrawal Syndrome in Parkinson Disease

(2010) Christina A. Rabinak et al.   ARCHIVES OF NEUROLOGY

Impulse Control Disorders in Parkinson Disease

(2010) Daniel Weintraub et al.   ARCHIVES OF NEUROLOGY

Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature

(2010) Patrice Péran et al.   BRAIN

Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson’s disease

(2010) Maria C. Rodriguez-Oroz et al.   BRAIN

Consensus Statement of the Movement Disorder Society on Tremor

(2010) Günther Deuschl et al.   MOVEMENT DISORDERS

A historical analysis of the relationship between encephalitis lethargica and postencephalitic parkinsonism: A complex rather than a direct relationship

(2010) Joel A. Vilensky et al.   MOVEMENT DISORDERS

The changing face of Parkinson's disease-associated psychosis: A cross-sectional study based on the new NINDS-NIMH criteria

(2010) Gilles Fénelon et al.   MOVEMENT DISORDERS

Parkinson's disease tremor-related metabolic network: Characterization, progression, and treatment effects

(2010) Hideo Mure et al.   NEUROIMAGE

Regional patterns of brain tissue loss associated with depression in Parkinson disease

(2010) V. S. Kostic et al.   NEUROLOGY

Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures

(2010) M. Politis et al.   NEUROLOGY

α-Synuclein Suppression by Targeted Small Interfering RNA in the Primate Substantia Nigra

(2010) Alison L. McCormack et al.   PLoS One

Lessons from the rotenone model of Parkinson's disease

(2010) J. Timothy Greenamyre et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study

(2009) R. Nandhagopal et al.   BRAIN

Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria

(2009) Dennis W Dickson et al.   LANCET NEUROLOGY

Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra Neurons

(2009) Eugene V. Mosharov et al.   NEURON

A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease

(2009) C. Warren Olanow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of  -synuclein

(2009) P. Desplats et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Exogenous  -synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells

(2009) K. C. Luk et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Metabolic brain networks in neurodegenerative disorders: a functional imaging approach

(2009) David Eidelberg   TRENDS IN NEUROSCIENCES

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography

(2008) P Edison et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial

(2008) William J Marks et al.   LANCET NEUROLOGY

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

(2008) Daniel G Healy et al.   LANCET NEUROLOGY

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

(2008) Mariese A. Hely et al.   MOVEMENT DISORDERS

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

(2008) Jia-Yi Li et al.   NATURE MEDICINE

Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease

(2008) Jeffrey H Kordower et al.   NATURE MEDICINE

A controlled trial of antidepressants in patients with Parkinson disease and depression

(2008) M. Menza et al.   NEUROLOGY

Patterns and stages of  -synucleinopathy: Relevance in a population-based cohort

(2008) J. Zaccai et al.   NEUROLOGY

Imaging amyloid deposition in Lewy body diseases

(2008) S. N. Gomperts et al.   NEUROLOGY

Second consensus statement on the diagnosis of multiple system atrophy

(2008) S. Gilman et al.   NEUROLOGY

Midbrain iron content in early Parkinson disease: A potential biomarker of disease status

(2008) W. R. W. Martin et al.   NEUROLOGY

The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of α-synuclein staging

(2008) M. E. Kalaitzakis et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Lewy body pathology in long-term fetal nigral transplants: is parkinson's disease transmitted from one neural system to another?

(2008) Jeffrey H Kordower et al.   NEUROPSYCHOPHARMACOLOGY

Glial reactions in Parkinson's disease

(2007) Patrick L. McGeer et al.   MOVEMENT DISORDERS